Selected article for: "age breed size and breed size age"
Title: Research Communications of the 24th ECVIM-CA Congress
  • Document date: 2015_1_10
    • ID: r59usk02_382
    Snippet: Dr. Steiner serves as Director and Dr. Suchodolski serves as Associate Director of the Gastrointestinal Laboratory at texas A&M University. Dr. Steiner also serves as a paid consultant to Idexx Laboratories, Westbrook, ME, USA. Both the Gastrointestinal Laboratory and Idexx Laboratories offer cPLI and fPLI testing on a fee-for-service basis. Digestive health is a main concern for growth, morbidity and mortality in weaning puppies. Fecal immunoglo.....
    Document: Dr. Steiner serves as Director and Dr. Suchodolski serves as Associate Director of the Gastrointestinal Laboratory at texas A&M University. Dr. Steiner also serves as a paid consultant to Idexx Laboratories, Westbrook, ME, USA. Both the Gastrointestinal Laboratory and Idexx Laboratories offer cPLI and fPLI testing on a fee-for-service basis. Digestive health is a main concern for growth, morbidity and mortality in weaning puppies. Fecal immunoglobulin A (IgA) has been suggested as a useful noninvasive biomarker for mucosal immunity. The purpose of this study was to evaluate the effect of infection with enteropathogens on fecal IgA concentrations in puppies and that of physiological factors such as age and breed size.

    Search related documents:
    Co phrase search for related documents
    • breed size age and IgA concentration: 1, 2, 3
    • breed size age and mucosal immunity: 1
    • breed size and enteropathogen infection: 1, 2, 3, 4
    • breed size and IgA concentration: 1, 2, 3, 4
    • breed size and mucosal immunity: 1
    • digestive health and enteropathogen infection: 1
    • digestive health and IgA concentration: 1
    • enteropathogen infection and IgA concentration: 1, 2, 3, 4
    • enteropathogen infection and mucosal immunity: 1
    • fecal immunoglobulin and IgA concentration: 1
    • fecal immunoglobulin and iga fecal immunoglobulin: 1, 2, 3, 4, 5
    • IgA concentration and mucosal immunity: 1, 2
    • main concern and mortality morbidity: 1
    • mortality morbidity and mucosal immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • mortality morbidity and noninvasive biomarker: 1
    • mucosal immunity and noninvasive biomarker: 1